New patent for the drug Par Sterile VASOSTRICT – DrugPatentWatch
Annual Drug Patent Expiration for VASOSTRICT
Vasostrict is a drug marketed by Par Sterile Products and included in one NDA. It is available from six suppliers. There are fourteen patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for VASOSTRICT.
The generic ingredient in VASOSTRICT is vasopressin. Six registered suppliers for this complex. Additional details are available on the vasopressin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New Patent for the drug Par Sterile VASOSTRICT
